Document is current
Any future updates will be listed below
-
Authors
Bode, Hannes Frederik
He, Liang
Hjelmborg, Jacob V. B.
Kaprio, Jaakko
Ollikainen, Miina
-
Funding
Funding for this research was provided by:
Faculty of Health Sciences, University of Southern Denmark, Denmark
AgeCare program of the Academy of Geriatric Cancer Research, Odense University Hospital, Denmark
the European Union’s Horizon 2020 Research and Innovation Programme, Marie Skłodowska-Curie (859860)
Research Council of Finland (336823, 297908)
Sigrid Juselius Foundation
University of Helsinki
- License Information
-
More Information
Article History
Received: 12 March 2024
Accepted: 23 October 2024
First Online: 18 November 2024
Declarations
:
: Informed consent was obtained before the beginning of the FTC studies in 1975, and upon every contact with the study subjects. When clinical investigations were undertaken with sampling of biological material, written informed consent was obtained. Ethics approval of these procedures was provided in multiple studies, the last one on the transfer of biological samples to the THL Biobank by the Hospital District of Helsinki and Uusimaa ethics board in 2018 (#1799/2017). Permission for register linkage to the Finnish Cancer Registry was given by the Finnish Social and Health Data Permit Authority Findata (latest THL/6353/14.06.00/2023).
: The two Danish twin studies (LSADT and MADT) were approved by the Regional Committees on Health Research Ethics for Southern Denmark (S-VF-19980072), and written informed consents were obtained from all participants.
: The authors declare no competing interests.
